Cargando…

Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo

Vitiligo is a depigmentation disease that seriously affects the physical health, mental health and quality of life of a patient. Therapeutic aim at control immunoreaction by relieving oxidative stress. Unfortunately, the cuticle barrier function and lack of specific accumulation lead to unsatisfacto...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ming-Chen, Xu, Xiao-Ling, Lou, Xue-Fang, Du, Yong-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217315/
https://www.ncbi.nlm.nih.gov/pubmed/32440123
http://dx.doi.org/10.2147/IJN.S245326
_version_ 1783532591438102528
author Sun, Ming-Chen
Xu, Xiao-Ling
Lou, Xue-Fang
Du, Yong-Zhong
author_facet Sun, Ming-Chen
Xu, Xiao-Ling
Lou, Xue-Fang
Du, Yong-Zhong
author_sort Sun, Ming-Chen
collection PubMed
description Vitiligo is a depigmentation disease that seriously affects the physical health, mental health and quality of life of a patient. Therapeutic aim at control immunoreaction by relieving oxidative stress. Unfortunately, the cuticle barrier function and lack of specific accumulation lead to unsatisfactory therapeutic outcomes and side effects. The introduction and innovation of nanotechnology offers inspiration and clues for the development of new strategies to treat vitiligo. However, not many studies have been done to interrogate how nanotechnology can be used for vitiligo treatment. In this review, we summarize and analyze recent studies involving nano-drug delivery systems for the treatment of vitiligo, with a special emphasis on liposomes, niosomes, nanohydrogel and nanoparticles. These studies made significant progress by either increasing drug loading efficiency or enhancing penetration. Based on these studies, there are three proposed principles for topical nano-drug delivery systems treatment of vitiligo including the promotion of transdermal penetration, enhancement of drug retention and facilitation of melanin regeneration. The presentation of these ideas may provide inspirations for the future development of topical drug delivery systems that will conquer vitiligo.
format Online
Article
Text
id pubmed-7217315
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72173152020-05-21 Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo Sun, Ming-Chen Xu, Xiao-Ling Lou, Xue-Fang Du, Yong-Zhong Int J Nanomedicine Review Vitiligo is a depigmentation disease that seriously affects the physical health, mental health and quality of life of a patient. Therapeutic aim at control immunoreaction by relieving oxidative stress. Unfortunately, the cuticle barrier function and lack of specific accumulation lead to unsatisfactory therapeutic outcomes and side effects. The introduction and innovation of nanotechnology offers inspiration and clues for the development of new strategies to treat vitiligo. However, not many studies have been done to interrogate how nanotechnology can be used for vitiligo treatment. In this review, we summarize and analyze recent studies involving nano-drug delivery systems for the treatment of vitiligo, with a special emphasis on liposomes, niosomes, nanohydrogel and nanoparticles. These studies made significant progress by either increasing drug loading efficiency or enhancing penetration. Based on these studies, there are three proposed principles for topical nano-drug delivery systems treatment of vitiligo including the promotion of transdermal penetration, enhancement of drug retention and facilitation of melanin regeneration. The presentation of these ideas may provide inspirations for the future development of topical drug delivery systems that will conquer vitiligo. Dove 2020-05-08 /pmc/articles/PMC7217315/ /pubmed/32440123 http://dx.doi.org/10.2147/IJN.S245326 Text en © 2020 Sun et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Sun, Ming-Chen
Xu, Xiao-Ling
Lou, Xue-Fang
Du, Yong-Zhong
Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
title Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
title_full Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
title_fullStr Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
title_full_unstemmed Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
title_short Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
title_sort recent progress and future directions: the nano-drug delivery system for the treatment of vitiligo
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217315/
https://www.ncbi.nlm.nih.gov/pubmed/32440123
http://dx.doi.org/10.2147/IJN.S245326
work_keys_str_mv AT sunmingchen recentprogressandfuturedirectionsthenanodrugdeliverysystemforthetreatmentofvitiligo
AT xuxiaoling recentprogressandfuturedirectionsthenanodrugdeliverysystemforthetreatmentofvitiligo
AT louxuefang recentprogressandfuturedirectionsthenanodrugdeliverysystemforthetreatmentofvitiligo
AT duyongzhong recentprogressandfuturedirectionsthenanodrugdeliverysystemforthetreatmentofvitiligo